RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Studying Anorectal malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- Tirzepatide(drug)
- Enrollment
- 200 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- Medical Dermatology Specialists, Phoenix, Arizona, United States
- First OC Dermatology Research Inc, Fountain Valley, California, United States
- Center For Dermatology Clinical Research, Inc., Fremont, California, United States
- Metropolis Dermatology, Los Angeles, California, United States
- Northridge Clinical Trials, Northridge, California, United States
- Alliance for Multispecialty Research, LLC, Fort Myers, Florida, United States
- NeoClinical Research, Hialeah, Florida, United States
- Skin Care Research, Hollywood, Florida, United States
- Encore Medical Research, Hollywood, Florida, United States
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research, Tampa, Florida, United States
- TruDerm & TruSpa, Wellington, Florida, United States
- Southeast Research Specialists, Douglasville, Georgia, United States
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
- The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
- Equity Medical - Bowling Green, Bowling Green, Kentucky, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06857942 on ClinicalTrials.govOther trials for Anorectal malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07441083Efficacy and Safety of Shatavari Root Extract in Women's Sexual WellnessSF Research Institute, Inc.
- RECRUITINGPHASE1NCT07545967Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After RadiotherapyWest China Hospital
- RECRUITINGNCT07438691Outcomes in ARMs: Comparison Between Surgical Techniques in Patients With Perineal or Vestibular Fistula - a Multicenter Italian StudyMeyer Children's Hospital IRCCS
- RECRUITINGNCT07174388A Study in Non-Small Cell Lung CancerN-Power Medicine
- RECRUITINGNANCT07366476Effectiveness of Electrical Stimulation and Biofeedback on Fecal Incontinence in Children With Repaired Anorectal MalformationSinai University
- RECRUITINGPHASE2NCT07311577Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical StudyJiangsu Cancer Institute & Hospital
- RECRUITINGPHASE2, PHASE3NCT07369739Golidocitinib Combined With Selinexor for CAEBVDBeijing Friendship Hospital
- RECRUITINGNANCT07263451Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory StudyTian'an Jiang